Tudor Investment Corp
AMRX icon

Tudor Investment Corp’s Amneal Pharmaceuticals AMRX Stock Holding History

Tudor Investment Corp’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-53,288
Closed -$671K – 3555
2025
Q4 		$671K Sell
53,288
-38,722
-42% -$443K ﹤0.01% 2544
2025
Q3 		$921K Buy
+92,010
New +$826K ﹤0.01% 2328
2025
Q2 		– Sell
-152,304
Closed -$1.28M – 3205
2025
Q1 		$1.28M Buy
+152,304
New +$1.27M ﹤0.01% 1653
2021
Q2 		– Sell
-13,838
Closed -$93K – 1582
2021
Q1 		$93K Buy
+13,838
New +$76.7K ﹤0.01% 1490

Other funds holding AMRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return